학술논문
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
Document Type
Article
Author
Hutchings, Martin ; Mous, Rogier; Clausen, Michael Roost; Johnson, Peter; Linton, Kim M; Chamuleau, Martine E D; Lewis, David John; Sureda Balari, Anna; Cunningham, David; Oliveri, Roberto S; Elliott, Brian; DeMarco, Dena; Azaryan, Ada; Chiu, Christopher; Li, Tommy; Chen, Kuo-mei; Ahmadi, Tahamtan; Lugtenburg, Pieternella J
Source
In The Lancet 25 September-1 October 2021 398(10306):1157-1169
Subject
Language
ISSN
0140-6736